Notice2024-16504

Meeting of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
July 26, 2024

Issuing agencies

Health and Human Services DepartmentHealth Resources and Services Administration

Abstract

In accordance with the Federal Advisory Committee Act, this notice announces that the Centers for Disease Control and Prevention (CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC) has scheduled a public meeting. Information about CHAC and the meeting can be found on the CHAC website at https://www.cdc.gov/faca/committees/chachspt.html and the meeting website at https://targethiv.org/events/chac.

Full Text

<html>
<head>
<title>Federal Register, Volume 89 Issue 144 (Friday, July 26, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 144 (Friday, July 26, 2024)]
[Notices]
[Pages 60643-60644]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-16504]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis, and STD Prevention and Treatment

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Centers for Disease Control and Prevention 
(CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and STD 
Prevention and Treatment (CHAC) has scheduled a public meeting. 
Information about CHAC and the meeting can be found on the CHAC website 
at <a href="https://www.cdc.gov/faca/committees/chachspt.html">https://www.cdc.gov/faca/committees/chachspt.html</a> and the meeting 
website at <a href="https://targethiv.org/events/chac">https://targethiv.org/events/chac</a>.

DATES: October 21, 2024, 9 a.m. to 5 p.m. eastern time (ET) and October 
22, 2024, 9 a.m. to 3 p.m. ET.

ADDRESSES: This meeting will be hybrid, held both virtually through 
Zoom and in-person at 5600 Fishers Lane in Rockville, Maryland, 20857. 
Advance registration is required to attend. Please visit the meeting 
website to register. Registration will open in August. The in-person 
registration deadline is

[[Page 60644]]

Monday, October 14, 2024, at 5 p.m. ET; registration for virtual 
attendance will remain open. Prior to the meeting, each individual 
registrant will receive a registration confirmation along with an 
access link to the virtual meeting location.

FOR FURTHER INFORMATION CONTACT: Breana Alsworth, Public Health 
Analyst, HIV/AIDS Bureau, HRSA, 5600 Fishers Lane, Rockville, Maryland 
20857; (301) 443-1134; or <a href="/cdn-cgi/l/email-protection#d19299909290b5a7b8a2bea3a892bebcbc91b9a3a2b0ffb6bea7"><span class="__cf_email__" data-cfemail="cd8e858c8e8ca9bba4bea2bfb48ea2a0a08da5bfbeace3aaa2bb">[email&#160;protected]</span></a>.

SUPPLEMENTARY INFORMATION: CHAC provides advice and recommendations to 
the Secretary of HHS on policy, program development, and other matters 
of significance concerning the activities under section 222 of the 
Public Health Service Act, 42 U.S.C. 217a.
    The purpose of CHAC is to advise the Secretary of HHS, CDC 
Director, and HRSA Administrator regarding objectives, strategies, 
policies, and priorities for the prevention and treatment of HIV, viral 
hepatitis, and other STDs, including surveillance, epidemiologic, 
behavioral, health services, and laboratory research, identification of 
policy issues related to professional education, patient healthcare 
delivery, and prevention services; agency policies regarding health 
care delivery, research and training; strategic issues influencing the 
ability of CDC and HRSA to fulfill their missions' programmatic efforts 
to prevent and treat HIV, viral hepatitis, and other STDs; and support 
to CDC and HRSA in their development of responses to emerging health 
needs related to these issues.
    During the October 21-22, 2024, meeting, CHAC will discuss issues 
related to re-engaging people with HIV out of care (including data-to-
care strategies and overcoming barriers to care), the use of long-
acting injectables for HIV care and treatment and increasing access to 
mental health services for people with HIV and STDs. Agenda items are 
subject to change as priorities dictate. Please refer to the CHAC 
meeting information page listed above for any updated meeting 
information.
    Members of the public will have the opportunity to provide 
comments. Public participants may also submit written statements as 
further described below. Oral comments will be honored in the order 
they are requested and may be limited as time allows. Requests to 
submit a written statement or make oral comments to CHAC should be sent 
via the meeting website at <a href="https://targethiv.org/events/chac">https://targethiv.org/events/chac</a> after 
registration has opened. Requests for oral comment must be received by 
October 11, 2024, at 5:00 p.m. ET to be considered. Written comments 
may be submitted to Breana Alsworth (<a href="/cdn-cgi/l/email-protection#f4b7bcb5b7b590829d879b868db79b9999b49c868795da939b82"><span class="__cf_email__" data-cfemail="c18289808280a5b7a8b2aeb3b882aeacac81a9b3b2a0efa6aeb7">[email&#160;protected]</span></a>) prior 
to and up to 10 business days after the meeting. Visit the meeting 
information page for additional details: <a href="https://targethiv.org/events/chac">https://targethiv.org/events/chac</a>.
    Individuals who plan to attend and need special assistance or 
another reasonable accommodation should notify Breana Alsworth 
(<a href="/cdn-cgi/l/email-protection#adeee5eceeecc9dbc4dec2dfd4eec2c0c0edc5dfdecc83cac2db"><span class="__cf_email__" data-cfemail="74373c35373510021d071b060d371b1919341c0607155a131b02">[email&#160;protected]</span></a>) at least 10 business days prior to the 
meeting. Since this meeting occurs in a Federal Government building, 
attendees must go through a security check to enter the building. Non-
U.S. Citizen attendees must notify HRSA of their planned attendance at 
least 20 business days prior to the meeting to facilitate their entry 
into the building. All attendees are required to present government-
issued identification prior to entry.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024-16504 Filed 7-25-24; 8:45 am]
BILLING CODE 4165-15-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on July 26, 2024.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.